UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income	$ 44,490	$ 44,855
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	0	4,057
Depreciation and amortization	1,443	1,196
Net (accretion) amortization of securities premiums and discounts	(780)	35
Increase (decrease) in cash surrender value of BOLI	1,276	(950)
Gain on BOLI death benefit	0	(4,346)
Decrease in deferred income taxes, net	7,854	1,773
Loss on sale of securities available-for-sale	0	5,686
Net changes in:
Other assets	(6,714)	(2,636)
Other liabilities	7,526	16,671
Net cash provided by operating activities	55,095	66,341
Cash flows from investing activities:
Net change in loans and leases held for investment	(27,594)	6,388
Purchase of available-for-sale securities	(83,361)	(4,515)
Purchase of held-to-maturity securities	(2,028)	(2,071)
Proceeds from sales, maturities, calls and pay downs of available-for-sale securities	11,667	43,885
Proceeds from maturities, calls and pay downs of held-to-maturity securities	25,054	23,498
Purchase of premises and equipment	(844)	(3,239)
Purchase of other investments	(11,227)	(2,166)
Redemption of other investments	5,000	0
Proceeds from bank-owned life insurance	0	11,752
Proceeds from sale of assets	0	27
Net cash (used in) provided by investing activities	(83,333)	73,559
Cash flows from financing activities:
Net decrease in deposits	(71,040)	(120,956)
Cash dividends paid	(6,507)	(6,286)
Net cash used in share repurchases of common stock	(8,921)	(13,943)
Net cash (used in) financing activities	(86,468)	(141,185)
Net change in cash and cash equivalents	(114,706)	(1,285)
Cash and cash equivalents, beginning of period	410,642	588,257
Cash and cash equivalents, end of period	295,936	586,972
Supplemental disclosures of cash flow information:
Cash paid for interest	34,423	9,907
Income taxes paid	7,349	16
Supplemental disclosures of non-cash transactions:
Net change in unrealized gains on securities available-for-sale	$ 3,695	$ 6,857